Insider · CIK 0001871563
Ronit Simantov
Files at TPST (Tempest Therapeutics, Inc.), GMDA (Gamida Cell Ltd.). First filing -, latest -.
In brief
Ronit Simantov files SEC Form 4 as director and officer at TPST (Tempest Therapeutics, Inc.), and also at GMDA (Gamida Cell Ltd.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ronit Simantov has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026 | TPST Tempest Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +1,230 | $0.00 | $0 | 1,230 | Jan 28, 2026 |
| Jan 31, 2024 | GMDA Gamida Cell Ltd. | AGrant or award Ordinary Shares | +480,319 | $0.00 | $0 | 655,896 | Feb 2, 2024 |
Questions about Ronit Simantov
Answered from the filings on this page, as of the latest one.
Is Ronit Simantov buying or selling?
Ronit Simantov has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ronit Simantov's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ronit Simantov has 0.
Where does Ronit Simantov file Form 4?
Ronit Simantov has filed Form 4 at TPST (Tempest Therapeutics, Inc.); GMDA (Gamida Cell Ltd.) as CMO & CHIEF SCIENTIFIC OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.